# Research In Viral Eradication of HIV Reservoirs

> **NCT02336074** · PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 60 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Combination Antiretroviral Therapy (cART)
- **DRUG:** Raltegravir
- **DRUG:** Vorinostat
- **BIOLOGICAL:** ChAdV63.HIVconsv (ChAd)
- **BIOLOGICAL:** MVA.HIVconsv (MVA)

## Key facts

- **NCT ID:** NCT02336074
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-27
- **Primary completion:** 2017-11-15
- **Final completion:** 2023-03-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336074, "Research In Viral Eradication of HIV Reservoirs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02336074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*